154 related articles for article (PubMed ID: 19760589)
41. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
[TBL] [Abstract][Full Text] [Related]
42. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
43. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.
Craig VJ; Cogliatti SB; Imig J; Renner C; Neuenschwander S; Rehrauer H; Schlapbach R; Dirnhofer S; Tzankov A; Müller A
Blood; 2011 Jun; 117(23):6227-36. PubMed ID: 21460242
[TBL] [Abstract][Full Text] [Related]
44. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
45. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.
Sol Mateo M; Mollejo M; Villuendas R; Algara P; Sánchez-Beato M; Martinez-Delgado B; Martínez P; Piris MA
Mol Pathol; 1998 Oct; 51(5):262-7. PubMed ID: 10193520
[TBL] [Abstract][Full Text] [Related]
46. Methylation patterns in marginal zone lymphoma.
Arribas AJ; Bertoni F
Best Pract Res Clin Haematol; 2017; 30(1-2):24-31. PubMed ID: 28288713
[TBL] [Abstract][Full Text] [Related]
47. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
48. Splenic marginal-zone lymphoma: ontogeny and genetics.
Baliakas P; Strefford JC; Bikos V; Parry M; Stamatopoulos K; Oscier D
Leuk Lymphoma; 2015 Feb; 56(2):301-10. PubMed ID: 24798744
[TBL] [Abstract][Full Text] [Related]
49. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities.
Ott MM; Rosenwald A; Katzenberger T; Dreyling M; Krumdiek AK; Kalla J; Greiner A; Ott G; Müller-Hermelink HK
Genes Chromosomes Cancer; 2000 Aug; 28(4):380-6. PubMed ID: 10862046
[TBL] [Abstract][Full Text] [Related]
50. Expression of FOXP1 and Colorectal Cancer Prognosis.
De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
[TBL] [Abstract][Full Text] [Related]
51. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization.
Andersen CL; Gruszka-Westwood A; Atkinson S; Matutes E; Catovsky D; Pedersen RK; Pedersen BB; Pulczynski S; Hokland P; Jacobsen E; Koch J
Cancer Genet Cytogenet; 2005 Jan; 156(2):122-8. PubMed ID: 15642391
[TBL] [Abstract][Full Text] [Related]
52. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
[TBL] [Abstract][Full Text] [Related]
53. Recurrent genomic rearrangements in primary testicular lymphoma.
Twa DD; Mottok A; Chan FC; Ben-Neriah S; Woolcock BW; Tan KL; Mungall AJ; McDonald H; Zhao Y; Lim RS; Nelson BH; Milne K; Shah SP; Morin RD; Marra MA; Scott DW; Gascoyne RD; Steidl C
J Pathol; 2015 Jun; 236(2):136-41. PubMed ID: 25712539
[TBL] [Abstract][Full Text] [Related]
54. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.
Arribas AJ; Gómez-Abad C; Sánchez-Beato M; Martinez N; Dilisio L; Casado F; Cruz MA; Algara P; Piris MA; Mollejo M
Mod Pathol; 2013 Jul; 26(7):889-901. PubMed ID: 23429603
[TBL] [Abstract][Full Text] [Related]
55. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas.
Brynes RK; Almaguer PD; Leathery KE; McCourty A; Arber DA; Medeiros LJ; Nathwani BN
Mod Pathol; 1996 Oct; 9(10):995-1000. PubMed ID: 8902837
[TBL] [Abstract][Full Text] [Related]
56. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH.
Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D
Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800
[TBL] [Abstract][Full Text] [Related]
57. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.
Hernández JM; García JL; Gutiérrez NC; Mollejo M; Martínez-Climent JA; Flores T; González MB; Piris MA; San Miguel JF
Am J Pathol; 2001 May; 158(5):1843-50. PubMed ID: 11337382
[TBL] [Abstract][Full Text] [Related]
58. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
[TBL] [Abstract][Full Text] [Related]
59. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract.
Barth TF; Bentz M; Leithäuser F; Stilgenbauer S; Siebert R; Schlotter M; Schlenk RF; Döhner H; Möller P
Genes Chromosomes Cancer; 2001 Aug; 31(4):316-25. PubMed ID: 11433522
[TBL] [Abstract][Full Text] [Related]
60. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
